<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>05902643976504</udiDi>
    <basicUdiDi>59026439BBMTGCK9</basicUdiDi>
    <tradeName>TIGECYCLINE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0150B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:44.991Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643976467</udiDi>
    <basicUdiDi>59026439BBMTEL5</basicUdiDi>
    <tradeName>TETRACYCLINE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0146B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:43.764Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643976412</udiDi>
    <basicUdiDi>59026439BBMTECK3</basicUdiDi>
    <tradeName>TEICOPLANIN</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0141B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:42.566Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643976368</udiDi>
    <basicUdiDi>59026439BBMSPE</basicUdiDi>
    <tradeName>STREPTOMYCIN</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0136B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:41.362Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643976238</udiDi>
    <basicUdiDi>59026439BBMTZPMU</basicUdiDi>
    <tradeName>PIPERACILLIN-TAZOBACTAM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0123B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:40.160Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643976221</udiDi>
    <basicUdiDi>59026439BBMPRLL8</basicUdiDi>
    <tradeName>PIPERACILLIN</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0122B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:38.956Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643976207</udiDi>
    <basicUdiDi>59026439BBMPP8</basicUdiDi>
    <tradeName>PENICILLIN G</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0120B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:37.785Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643976146</udiDi>
    <basicUdiDi>59026439BBMOXLU</basicUdiDi>
    <tradeName>OXACILLIN</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0114B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:36.552Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643975972</udiDi>
    <basicUdiDi>59026439BBMMXFKX</basicUdiDi>
    <tradeName>MOXIFLOXACIN</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0097B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:35.398Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643975934</udiDi>
    <basicUdiDi>59026439BBMMETK2</basicUdiDi>
    <tradeName>METRONIDAZOLE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0093B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:34.148Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643975903</udiDi>
    <basicUdiDi>59026439BBMMEMJL</basicUdiDi>
    <tradeName>MEROPENEM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0090B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:32.985Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643975866</udiDi>
    <basicUdiDi>59026439BBMLNZL4</basicUdiDi>
    <tradeName>LINEZOLID</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0086B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:31.746Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643975842</udiDi>
    <basicUdiDi>59026439BBMLEVJZ</basicUdiDi>
    <tradeName>LEVOFLOXACIN</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0084B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:30.549Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643975781</udiDi>
    <basicUdiDi>59026439BBMIMPJW</basicUdiDi>
    <tradeName>IMIPENEM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0078B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:29.350Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643975750</udiDi>
    <basicUdiDi>59026439BBMCNK4</basicUdiDi>
    <tradeName>GENTAMICIN</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0075B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:28.182Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643975644</udiDi>
    <basicUdiDi>59026439BBMENJ</basicUdiDi>
    <tradeName>ERYTHROMYCIN</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0064B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:26.981Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643975637</udiDi>
    <basicUdiDi>59026439BBMETPJX</basicUdiDi>
    <tradeName>ERTAPENEM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0063B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:25.755Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643975507</udiDi>
    <basicUdiDi>59026439BBMDAJD</basicUdiDi>
    <tradeName>CLINDAMYCIN</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0050B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:24.542Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643975491</udiDi>
    <basicUdiDi>59026439BBMCLRHZ</basicUdiDi>
    <tradeName>CLARITHROMYCIN</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0049B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:23.346Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902643975477</udiDi>
    <basicUdiDi>59026439BBMCIPHL</basicUdiDi>
    <tradeName>CIPROFLOXACIN</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BioMaxima Spółka Akcyjna</manufacturerName>
    <manufacturerSrn>PL-MF-000039473</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0047B30</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:17:22.143Z</lastUpdated>
  </row>
</eudamedExport>